A study on the involvement of GABA-transaminase in MCT induced pulmonary hypertension. (February 2016)
- Record Type:
- Journal Article
- Title:
- A study on the involvement of GABA-transaminase in MCT induced pulmonary hypertension. (February 2016)
- Main Title:
- A study on the involvement of GABA-transaminase in MCT induced pulmonary hypertension
- Authors:
- Lingeshwar, Poorella
Kaur, Gurpreet
Singh, Neetu
Singh, Seema
Mishra, Akanksha
Shukla, Shubha
Ramakrishna, Rachumallu
Laxman, Tulsankar Sachin
Bhatta, Rabi Sankar
Siddiqui, Hefazat H.
Hanif, Kashif - Abstract:
- Abstract: Increased sympathetic nervous system (SNS) activity is associated with cardiovascular diseases but its role has not been completely explored in pulmonary hypertension (PH). Increased SNS activity is distinguished by elevated level of norepinephrine (NE) and activity of γ-Amino butyric acid Transminase (GABA-T) which degrades GABA, an inhibitory neurotransmitter within the central and peripheral nervous system. Therefore, we hypothesized that GABA-T may contribute in pathophysiology of PH by modulating level of GABA and NE. The effect of daily oral administration of GABA-T inhibitor, Vigabatrin (GVG, 50 and 75 mg/kg/day, 35 days) was studied following a single subcutaneous administration of monocrotaline (MCT, 60 mg/kg) in male SD rats. The pressure and hypertrophy of right ventricle (RV), oxidative stress, inflammation, pulmonary vascular remodelling were assessed after 35 days in MCT treated rats. The expression of GABA-T and HIF-1α was studied in lung tissue. The levels of plasma NE (by High performance liquid chromatography coupled with electrochemical detector; HPLC-ECD) and lung GABA (by liquid chromatography-mass spectrometry) were also estimated. GVG at both doses significantly attenuated increased in pressure (35.82 ± 4.80 mm Hg, p < 0.001; 28.37 ± 3.32 mm Hg, p < 0.001 respectively) and hypertrophy of RV, pulmonary vascular remodelling, oxidative stress and inflammation in lungs of MCT exposed rats. GVG also reduced the expression of GABA-T and HIF-1α inAbstract: Increased sympathetic nervous system (SNS) activity is associated with cardiovascular diseases but its role has not been completely explored in pulmonary hypertension (PH). Increased SNS activity is distinguished by elevated level of norepinephrine (NE) and activity of γ-Amino butyric acid Transminase (GABA-T) which degrades GABA, an inhibitory neurotransmitter within the central and peripheral nervous system. Therefore, we hypothesized that GABA-T may contribute in pathophysiology of PH by modulating level of GABA and NE. The effect of daily oral administration of GABA-T inhibitor, Vigabatrin (GVG, 50 and 75 mg/kg/day, 35 days) was studied following a single subcutaneous administration of monocrotaline (MCT, 60 mg/kg) in male SD rats. The pressure and hypertrophy of right ventricle (RV), oxidative stress, inflammation, pulmonary vascular remodelling were assessed after 35 days in MCT treated rats. The expression of GABA-T and HIF-1α was studied in lung tissue. The levels of plasma NE (by High performance liquid chromatography coupled with electrochemical detector; HPLC-ECD) and lung GABA (by liquid chromatography-mass spectrometry) were also estimated. GVG at both doses significantly attenuated increased in pressure (35.82 ± 4.80 mm Hg, p < 0.001; 28.37 ± 3.32 mm Hg, p < 0.001 respectively) and hypertrophy of RV, pulmonary vascular remodelling, oxidative stress and inflammation in lungs of MCT exposed rats. GVG also reduced the expression of GABA-T and HIF-1α in MCT treated rats. Increased NE level and decreased GABA level was also reversed by GVG in MCT exposed rats. GABA-T plays an important role in PH by modulating SNS activity and may be considered as a therapeutic target in PH. … (more)
- Is Part Of:
- Pulmonary pharmacology & therapeutics. Volume 36(2016:Feb.)
- Journal:
- Pulmonary pharmacology & therapeutics
- Issue:
- Volume 36(2016:Feb.)
- Issue Display:
- Volume 36 (2016)
- Year:
- 2016
- Volume:
- 36
- Issue Sort Value:
- 2016-0036-0000-0000
- Page Start:
- 10
- Page End:
- 21
- Publication Date:
- 2016-02
- Subjects:
- Pulmonary hypertension -- GABA -- Right ventricle hypertrophy -- GABA-T -- Nor-epinephrine
Respiratory organs -- Diseases -- Chemotherapy -- Periodicals
615.7205 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10945539 ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/pulmonary-pharmacology-and-therapeutics/ ↗ - DOI:
- 10.1016/j.pupt.2015.11.002 ↗
- Languages:
- English
- ISSNs:
- 1094-5539
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7156.978500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7272.xml